Stockhub

PharmAust Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

  • curprev 08:4508:45, 19 August 2022 >Nick 1,052 bytes +1,052 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == PharmAust Limited, a clinical-stage company, develops targeted cancer therapeutics for humans and animals. The company develops drugs for the treatment of various cancers, and viral and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug for the treatment of cancer. PharmAust has completed Phase 1 clinical trials with monepantel in human and dog diagnosed with solid tumors, as well as initia..."
Retrieved from "https://stockhub.co/research/PharmAust_Limited"